Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.45M Sell
13,233
-51
-0.4% -$5.45K 0.09% 169
2025
Q4
$1.33M Buy
13,284
+5,062
+62% +$519K 0.09% 179
2025
Q3
$858K Buy
8,222
+1,135
+16% +$113K 0.06% 248
2025
Q2
$681K Buy
+7,087
New +$688K 0.05% 277
2019
Q3
Sell
-200
Closed -$13K 172
2019
Q2
$13K Hold
200
0.01% 453
2019
Q1
$13K Hold
200
0.01% 431
2018
Q4
$12K Hold
200
0.01% 410
2018
Q3
$11K Hold
200
0.01% 447
2018
Q2
$11K Buy
200
+9
+5% +$517 0.01% 444
2018
Q1
$9K Sell
191
-39
-17% -$2.16K 0.01% 436
2017
Q4
$13K Buy
+230
New +$14.1K 0.01% 400

Other funds holding AEE

Avestar Capital's AEE Position: Q1 2026 in Review

Avestar Capital reduced its Ameren (AEE) stake by 0.38% in Q1 2026, selling an estimated $5.45K and leaving 13,233 shares worth $1.45M. The position accounts for 0.09% of the portfolio, ranked #169.

Avestar Capital first reported a position in AEE in Q4 2017 and has held it in 11 quarters since. 923 funds tracked by Wall St. Rank hold AEE as of Q1 2026.

  • Avestar Capital held 13,233 shares of Ameren worth $1.45M as of Q1 2026.
  • Avestar Capital sold 51 Ameren shares in Q1 2026, an estimated $5.45K.
  • Ameren made up 0.09% of Avestar Capital's portfolio in Q1 2026, its #169 holding.
  • Avestar Capital first reported a position in Ameren in Q4 2017 and has held it in 11 quarters since.
  • 923 funds tracked by Wall St. Rank held Ameren as of Q1 2026.

Based on Avestar Capital's 13F filing for Q1 2026, filed 13 May 2026.